Curocell Cash Flow Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Net Income	-46,305	-38,239	-29,575
Depreciation & Amortization	6,122	6,335	4,706
Loss (Gain) From Sale of Assets	-9.17	8.18	11.24
Stock-Based Compensation	953.87	1,522	1,410
Other Operating Activities	10,253	2,258	-1,590
Change in Inventory	-1,682	-	-
Change in Other Net Operating Assets	673.88	-416.78	-226.61
Operating Cash Flow	-29,993	-28,532	-25,264
Capital Expenditures	-313.23	-441.02	-21,164
Sale of Property, Plant & Equipment	12.55	-	30.91
Sale (Purchase) of Intangibles	-1,902	-768.92	-486.51
Investment in Securities	-7,196	23,500	500
Other Investing Activities	207.2	20	-7.24
Investing Cash Flow	-9,192	22,020	-21,127
Short-Term Debt Issued	-	-	1,000
Long-Term Debt Issued	43,000	-	46,899
Total Debt Issued	43,000	-	47,899
Short-Term Debt Repaid	-	-	-200
Long-Term Debt Repaid	-539	-507.5	-30,201
Total Debt Repaid	-539	-507.5	-30,401
Net Debt Issued (Repaid)	42,461	-507.5	17,497
Issuance of Common Stock	2,279	1,556	32,185
Other Financing Activities	56.84	103.14	-
Financing Cash Flow	44,797	1,152	49,682
Foreign Exchange Rate Adjustments	-27.96	23.53	-
Miscellaneous Cash Flow Adjustments	-0	0	-0
Net Cash Flow	5,584	-5,337	3,291
Free Cash Flow	-30,306	-28,973	-46,428
Free Cash Flow Per Share	-2115.32	-2072.99	-3923.32
Cash Interest Paid	1,575	1,921	1,401
Cash Income Tax Paid	-97.44	22.26	38.48
Levered Free Cash Flow	10,383	-18,421	-
Unlevered Free Cash Flow	13,223	-16,794	-
Change in Working Capital	-1,008	-416.78	-226.61

Source: S&P Global Market Intelligence. Standard template. Financial Sources.